Furthermore, as covalently modified MUC7 is reported to lose its potency against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans [20], the idea that HIV infection might induce structural changes to the mucins is perhaps a possibility. Here, MUC7 is linked to HIV infectious disease.